Federal contract award

75A50123C00046

ACQUIRE ASSAYS TO SUPPORT COVID-19 VACCINE DEVELOPMENT EFFORTS, IN RESPONSE TO BAA-18-100-SOL-00003, AREA OF INTEREST 8.4 COVID-19 IMMUNE ASSAYS(S) DEVELOPMENT AND IMPLEMENTATION.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeTIME AND MATERIALS
Obligations$23.2M
Current contract value$23.2M
Potential contract value / ceiling$23.2M
Start dateSep 29, 2023
Current end dateSep 28, 2026
Potential end dateSep 28, 2026
Latest award activityMar 23, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 23, 2026P00004$0EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI UNILATERAL MODIFICATION TO REFLECT PENDING DESCOPE AND DEOBLIGATION.
Sep 19, 2025P00003$0TO DEVELOP MULTIPLEXED SARS-COV-2 ANTIGEN PANEL ASSAY KITS FOR HUMAN ANTIBODY (E.G., IGA AND IGG WHEN APPROPRIATE) QUANTIFICATION BY ELECTROCHEMILUMINESCENCE IN SERUM AND MUCOSAL SAMPLES.
Dec 16, 2024P00002$0THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE SECTION G.1 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER TO LA VIVIAN PEASANT. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME.
Oct 24, 2024P00001$0THE PURPOSE OF THIS MODIFICATION TO UPDATE SECTION G.2 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER REPRESENTATIVE FROM MARCIELA DEGRACE TO LAKSHMI JAYASHANKAR.
Sep 29, 20230$23.2MACQUIRE ASSAYS TO SUPPORT COVID-19 VACCINE DEVELOPMENT EFFORTS, IN RESPONSE TO BAA-18-100-SOL-00003, AREA OF INTEREST 8.4 COVID-19 IMMUNE ASSAYS(S) DEVELOPMENT AND IMPLEMENTATION.

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.